Analyst Ratings For Ascendis Pharma A/S (NASDAQ:ASND)
Today, JPMorgan Chase & Co. raised its price target on Ascendis Pharma A/S (NASDAQ:ASND) to per share.
Some recent analyst ratings include
- 2/26/2018-Wedbush Reiterated Rating of Outperform.
- 1/19/2018-HC Wainwright Reiterated Rating of Buy.
- 9/22/2017-Wells Fargo Reiterated Rating of Buy.
- 9/1/2017-Leerink Swann Reiterated Rating of Hold.
Recent Trading Activity for Ascendis Pharma A/S (NASDAQ:ASND)
Shares of Ascendis Pharma A/S closed the previous trading session at with 0.0 shares trading hands.